Buy Cytokinetics Stock | CYTK Stock Price & Latest News | Public
CYTK

Cytokinetics

$0.00 (0.00%)Today

    About CYTK

    Cytokinetics, Inc. operates as a biopharmaceutical company, which focuses on the discovery and development of muscle activators as potential treatment for debilitating diseases. It conducts a Phase 2 clinical trials program for tirasemtiv, including a Phase 2b clinical ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.23
    -0.46
    -0.68
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.26

    Actual EPS
    Q4 2020

    Stats

    Market Cap$1,52B
    Volume40,59k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$29.20
    1 Year Low$7.72
    Open$21.82
    High$23.29
    Low$21.69

    Buy any stock with any amount of money.

    Download the App
    Download the app